Opening statements commenced on the 17th of August in Chicago. Inman v. Mead Johnson & Company, LLC (Case No. 1:22-cv-03737) marks the moment of impact. Jose Rojas of Levin, Rojas, Camassar & Reck LLC commands the courtroom for plaintiff Alexis Inman as jury selection and opening statements start today in Chicago.
State court juries have already obliterated these manufacturers. Missouri delivered a $495 million verdict in Gill v. Abbott. Cook County handed down a $70 million consolidated award. Corporate defendants expected the rigorous evidentiary gates of MDL 3026 to save them. Early summary judgment dismissals for Abbott provided false confidence. August 17 shatters that illusion.
Alexis Inman’s claims survived Daubert. Her legal team is armed and ready to dismantle Mead Johnson’s "Own the NICU" marketing strategy.
Plaintiffs' Playbook: Dictating the Science and Exposing Subversion
Epidemiology strongly favors our side. Peer-reviewed data confirms cow’s milk-based commercial formulas multiply the relative risk of necrotizing enterocolitis (NEC) by 2.14x compared to exclusive donor breast milk. Extreme prematurity accelerates this physiological vulnerability. Introducing bovine products too early creates a catastrophic gastrointestinal environment.
Proving this required surviving blistering defense attacks on our experts. Judge Rebecca R. Pallmeyer denied Mead Johnson's attempt to strike plaintiff-specific causation expert Dr. Chandani DeZure. Applying rigorous differential etiology, Dr. DeZure systematically isolated Enfamil Premature Formula (EPF) as the specific trigger for Daniel Windley’s fatal intestinal necrosis. General causation expert Dr. Logan Spector successfully defended his application of the Bradford Hill criteria. We dictate the scientific narrative from the opening bell.
Corporate malfeasance drives the liability here. Mead Johnson didn't just sell formula; they infiltrated hospital policy. Discovery unmasked their "Own the NICU" operation. They aggressively lobbied hospital nutritionists to adopt rigid feeding protocols like the Vidant Medical Center "Roadmap". Hospital staff forced extremely premature infants off safe donor milk and onto toxic, high-margin bovine products by day 27. We are weaponizing their internal documents to show juries these dietary transitions were driven by corporate profit, not medical necessity.
The Defense Playbook: Medical Necessity and Pecuniary Damage Caps
Defense counsel will try to gaslight the jury immediately. Their entire posture hinges on framing NEC as an inevitable "disease of prematurity". They argue infants like Daniel Windley—born at 29 weeks with Rh alloimmunization and profound medical comorbidities—were destined for severe outcomes regardless of enteral feeding regimens.
Expect the defense to weaponize the concept of medical necessity. They plan to tell the jury human milk alone lacks the caloric density required to keep these fragile infants alive. Abbott and Mead Johnson hide behind the American Academy of Pediatrics. Defense teams threaten that massive tort liabilities will collapse the specialized neonatal supply chain.
Statutory limitations have unfortunately reduced our financial leverage in this specific bellwether. Because Inman originated in Indiana, North Carolina substantive law applies. Judge Pallmeyer gutted the plaintiff's economic claims under restrictive wrongful death precedents, dismissing future lost income as purely speculative for a premature infant. Recoverable damages are strictly capped to the infant's pre-death pain and suffering. Mead Johnson secured a firewall against a massive runaway compensatory verdict here, but punitive exposure remains highly viable.
Regulatory Preemption Fails
Last-minute corporate panic manifested in a desperate preemption maneuver on August 5. Mead Johnson attempted to wield the Infant Formula Act (IFA) as an absolute liability shield. Citing the Supreme Court’s recent Monsanto Co. v. Durnell decision, they argued re-engineering their product to a safer lactose base would trigger federal regulatory wrath and constitute a conflict with existing approvals.
Judge Pallmeyer killed that argument instantly. Statutory mechanisms under the IFA operate as post-market notification, not a rigorous pre-market approval regime like Class III medical devices. FDA regulators do not affirmatively approve these exempt preterm formulas. State-law design defect claims proceed.
Jurisdictional Warfare: The 7th Circuit Trap
Corporate defense strategy relied heavily on dragging dangerous state court lawsuits into the federal MDL to suffocate them under Daubert gatekeeping. They exploited complete diversity rules by claiming plaintiffs "fraudulently joined" local hospitals and treating neonatologists.
Late last month, the Seventh Circuit incinerated that tactic. Appellate panels ruled subjective intent to prosecute is legally irrelevant. If a medical malpractice claim against a local NICU is theoretically viable under state law, federal courts cannot touch it.
Plaintiffs remain the masters of their domain. We keep our local hospital defendants attached to our complaints. Counsel will stay in state court venues where juries are actively handing down nine-figure punitive damage multipliers.
The Learned Intermediary Threat (Watson Reversal)
Do not underestimate the threat emerging from state appellate levels. June 2026 saw an Illinois appellate court overturn a $60 million verdict in Watson v. Mead Johnson. Appellate judges weaponized the learned intermediary doctrine, extending it for the first time to hospital-administered infant nutrition products.
Legal burdens of proof now shift across the entire mass tort arena. We can no longer win simply by showing emotional parents lacked informed consent. Plaintiffs must now prove Mead Johnson actively deceived highly trained neonatologists, and that an explicit warning label would have altered the doctor's expert feeding protocol. Future failure-to-warn strategies must center exclusively on physician manipulation. Watson's reversal also mandates strict compartmentalization of corporate wealth evidence solely to bifurcated punitive damage phases, insulating compensatory verdicts from inevitable appellate reversal.